Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
28.2 (1y: +58%)
Market Cap 381 M P/E(ttm) 22.00
Enterprise Value 311.22 M P/B 4.40
MED- NYSE (USA)
Medifast, Inc.
  • Currently 5/5
Business Predictability Rank: 5-Star
Back Testing Results:
Average gain of all 5-Star stocks: 12.1% per year.
% of Stocks that are in still loss if held for 10yrs: 3%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$28.20
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry		 vs
history
Cash to Debt 13.833
MED's Cash to Debt is ranked higher than
64% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.99 vs. MED: 13.833 )
MED' s 10-Year Cash to Debt Range
Min: 0.11   Max: 13.83
Current: 13.83
0.11
13.83
Equity to Asset 0.694
MED's Equity to Asset is ranked higher than
85% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.42 vs. MED: 0.694 )
MED' s 10-Year Equity to Asset Range
Min: -0.1   Max: 0.76
Current: 0.69
-0.1
0.76
Interest Coverage No Debt
MED's Interest Coverage is ranked higher than
69% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 71.00 vs. MED: No Debt )
MED' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: No Debt
F-Score: 8
Z-Score: 10.66
M-Score: -3.34
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 6.50
MED's Operating margin (%) is ranked higher than
80% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.20 vs. MED: 6.50 )
MED' s 10-Year Operating margin (%) Range
Min: -44.4   Max: 14.8
Current: 6.5
-44.4
14.8
Net-margin (%) 4.5
MED's Net-margin (%) is ranked higher than
85% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.15 vs. MED: 4.5 )
MED' s 10-Year Net-margin (%) Range
Min: -68.6   Max: 33.4
Current: 4.5
-68.6
33.4
ROE (%) 17.5
MED's ROE (%) is ranked higher than
94% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.00 vs. MED: 17.5 )
MED' s 10-Year ROE (%) Range
Min: 9.1   Max: 107.7
Current: 17.5
9.1
107.7
ROA (%) 12.2
MED's ROA (%) is ranked higher than
96% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.80 vs. MED: 12.2 )
MED' s 10-Year ROA (%) Range
Min: -151.1   Max: 41.7
Current: 12.2
-151.1
41.7
ROC (Joel Greenblatt) (%) 57.50
MED's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 10.80 vs. MED: 57.50 )
MED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -203.2   Max: 75.7
Current: 57.5
-203.2
75.7
Revenue Growth (%) 23.3
MED's Revenue Growth (%) is ranked higher than
99% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.90 vs. MED: 23.3 )
MED' s 10-Year Revenue Growth (%) Range
Min: 13.5   Max: 44.6
Current: 23.3
13.5
44.6
EBITDA Growth (%) 10.7
MED's EBITDA Growth (%) is ranked higher than
95% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.10 vs. MED: 10.7 )
MED' s 10-Year EBITDA Growth (%) Range
Min: 10.7   Max: 53.6
Current: 10.7
10.7
53.6
EPS Growth (%) 9.4
MED's EPS Growth (%) is ranked higher than
94% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 11.65 vs. MED: 9.4 )
MED' s 10-Year EPS Growth (%) Range
Min: -10.8   Max: 48.2
Current: 9.4
-10.8
48.2
» MED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

MED Guru Trades in Q2 2012

Richard Snow 28,355 sh (-0.19%)
Jim Simons 232,500 sh (-21.05%)
Joel Greenblatt 33,302 sh (-67.4%)
» More
Q3 2012

MED Guru Trades in Q3 2012

Steven Cohen 13,315 sh (New)
Jim Simons 318,100 sh (+36.82%)
Richard Snow Sold Out
Joel Greenblatt 25,273 sh (-24.11%)
» More
Q4 2012

MED Guru Trades in Q4 2012

Paul Tudor Jones 8,800 sh (New)
Steven Cohen 44,787 sh (+236.37%)
Jim Simons 420,900 sh (+32.32%)
Joel Greenblatt Sold Out
» More
Q1 2013

MED Guru Trades in Q1 2013

Richard Snow 40,700 sh (New)
Paul Tudor Jones 26,900 sh (+205.68%)
Jim Simons 396,700 sh (-5.75%)
Steven Cohen 27,698 sh (-38.16%)
» More
» Details

Insider Trades

Latest Guru Trades with MED

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2012-12-31 Sold Out 0.04%$25.41 - $32.28 $ 28.2-1%0
Joel Greenblatt 2012-09-30 Reduce -24.11%0.01%$19.97 - $28.75 $ 28.212%25273
Joel Greenblatt 2012-06-30 Reduce -67.4%0.11%$16.46 - $19.82 $ 28.253%33302
Joel Greenblatt 2012-03-31 Add 45.49%0.05%$14.78 - $17.73 $ 28.283%102169
Joel Greenblatt 2011-12-31 Add 31.87%0.03%$13.01 - $17.3 $ 28.285%70224
Joel Greenblatt 2011-09-30 Add 116.95%0.08%$14.46 - $24.36 $ 28.254%53253
George Soros 2011-09-30 Sold Out 0.0028%$14.46 - $24.36 $ 28.254%0
Joel Greenblatt 2011-06-30 New Buy0.08%$15.95 - $26.72 $ 28.231%24546
George Soros 2011-06-30 New Buy$15.95 - $26.72 $ 28.231%8500
George Soros 2010-12-31 Sold Out $23.25 - $31.29 $ 28.28%0
George Soros 2010-09-30 New Buy$24.1 - $32.5 $ 28.20%7500
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 22.00
MED's P/E(ttm) is ranked higher than
67% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 18.51 vs. MED: 22.00 )
MED' s 10-Year P/E(ttm) Range
Min: 0.75   Max: 104.82
Current: 22
0.75
104.82
P/B 4.40
MED's P/B is ranked lower than
80% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.40 vs. MED: 4.40 )
MED' s 10-Year P/B Range
Min: 0.51   Max: 21.68
Current: 4.4
0.51
21.68
P/S 1.07
MED's P/S is ranked lower than
71% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.50 vs. MED: 1.07 )
MED' s 10-Year P/S Range
Min: 0.23   Max: 7.92
Current: 1.07
0.23
7.92
PFCF 17.20
MED's PFCF is ranked higher than
63% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 14.90 vs. MED: 17.20 )
MED' s 10-Year PFCF Range
Min: 2.71   Max: 140.64
Current: 17.2
2.71
140.64
EV-to-EBIT 12
MED's EV-to-EBIT is ranked higher than
76% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.56 vs. MED: 12 )
MED' s 10-Year EV-to-EBIT Range
Min: 3.2   Max: 67
Current: 12
3.2
67
PEG 0.8
MED's PEG is ranked higher than
97% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.87 vs. MED: 0.8 )
MED' s 10-Year PEG Range
Min: 0.2   Max: 1.67
Current: 0.8
0.2
1.67
Shiller P/E 28.8
MED's Shiller P/E is ranked higher than
78% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 17.09 vs. MED: 28.8 )
MED' s 10-Year Shiller P/E Range
Min: 11.73   Max: 87.03
Current: 28.8
11.73
87.03

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 18.9
MED's Price/Net Cash is ranked higher than
97% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 11.10 vs. MED: 18.9 )
MED' s 10-Year Price/Net Cash Range
Min: 17.7   Max: 145.6
Current: 18.9
17.7
145.6
Price/Net Current Asset Value 28.8
MED's Price/Net Current Asset Value is ranked higher than
95% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.70 vs. MED: 28.8 )
MED' s 10-Year Price/Net Current Asset Value Range
Min: 3.4   Max: 88.7
Current: 28.8
3.4
88.7
Price/Tangible Book 4.3
MED's Price/Tangible Book is ranked higher than
87% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.30 vs. MED: 4.3 )
MED' s 10-Year Price/Tangible Book Range
Min: 0.7   Max: 12.2
Current: 4.3
0.7
12.2
Price/DCF (Projected) 1.3
MED's Price/DCF (Projected) is ranked higher than
89% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.00 vs. MED: 1.3 )
MED' s 10-Year Price/DCF (Projected) Range
Min: 1.1   Max: 10.7
Current: 1.3
1.1
10.7
Price/Median PS Value 0.8
MED's Price/Median PS Value is ranked higher than
72% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.80 vs. MED: 0.8 )
MED' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 4.5
Current: 0.8
0.2
4.5
Price/Peter Lynch Fair Value 0.9
MED's Price/Peter Lynch Fair Value is ranked higher than
90% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.20 vs. MED: 0.9 )
MED' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 3.5
Current: 0.9
0.4
3.5
Price/Graham Number 2.2
MED's Price/Graham Number is ranked higher than
81% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.60 vs. MED: 2.2 )
MED' s 10-Year Price/Graham Number Range
Min: 0.2   Max: 5.9
Current: 2.2
0.2
5.9
Earnings Yield (Greenblatt) 8.30
MED's Earnings Yield (Greenblatt) is ranked higher than
83% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 8.60 vs. MED: 8.30 )
MED' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 31.2
Current: 8.3
1.5
31.2
Forward Rate of Return (Yacktman) 31.11
MED's Forward Rate of Return (Yacktman) is ranked higher than
98% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 10.22 vs. MED: 31.11 )
MED' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 19.4   Max: 48.8
Current: 31.11
19.4
48.8

Business Description

Medifast, Inc. is a Delaware Corporation, incorporated in 1993. Medifast, Inc. The Company is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. Its product lines include weight and disease management, meal replacement, and vitamins mainly manufactured in its modern, FDA approved facility in Owings Mills, Maryland. The Company has two operating segments: Medifast and All Other. The Medifast segment consists of the following distribution channels: Medifast Direct, Take Shape for Life, and Doctors. The All Other segments consist of Hi-Energy and Medifast Weight Control Centers, the Company's parent company operations, as well as the Consumer Choice Systems, Inc. division which was sold in January of 2006. The Company offers a number of weight and disease management products under the Medifast brand and for select private label customers. The Medifast line includes Medifast 55 Shakes, Medifast 70 Shakes, Medifast Plus for Appetite Suppression Shakes, Medifast Plus for Women's Health Shakes, Medifast Plus for Diabetics Shakes, Medifast Plus for Joint Health Shakes, Medifast Plus for Coronary Health Shakes, New! Medifast Momentum Drinks, New! Momentum Flavor Infusers, New! Antioxidant Shakes, New! Antioxidant Flavor Infusers, New! Super Omega 3, Medifast Bars, New! Medifast Crispy Bars, Medifast Creamy Soups, Medifast Chicken Noodle Soup, Medifast Chicken & Wild Rice Soup, Medifast Beef Vegetable Stew, Medifast Home-style Chili, Medifast Oatmeal, Medifast Pudding, Medifast Scrambled Eggs, Medifast Hot Cocoa, Medifast Cappuccino, Medifast Chai Latte, Medifast Iced Teas, Medifast Fruit Drinks, Medifast Soy Crisps, and Medifast Crackers. Medifast nutritional products are formulated with high-quality, low-calorie, and low-fat ingredients. Many Medifast products are soy based and contain 24 vitamins and minerals, as well as other nutrients essential for good health. The Company uses Solae brand soy protein, which is a high-quality complete protein derived from soybeans. The Company's operations are mainly conducted through five of its wholly owned subsidiaries, Jason Pharmaceuticals, Inc., Take Shape for Life, Inc., Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. Many of its competitors are larger than it and have more financial resources to develop new products and programs. Some of its competitors are Jenny Craig, Nutrisystems, EDiets, Herbalife, and Weight Watchers. The formulation, processing, packaging, labeling and advertising of the Company's products is subject to regulation by several federal agencies, but mainly by the Food and Drug Administration.
Company Website
SEC Reports
Industry: Specialty Retail
Compare:TSCO, AMZN, EBAY, FIVE, AZO
Traded in other countries:MDF.Germany
» More Articles for MED

Headlines

Articles On GuruFocus.com
How Are GuruFocus Model Portfolios Faring Beside the Market in 2012? Dec 28 2012 
5-Star Predictable Companies with Highest ROA Mar 20 2012 
The Most Overpaid and Underpaid CEOs Jan 19 2012 
Medifast – 5-Star Predictability Rating Stock That Can Be Bought Cheaper Than Price Joel Greenblat Jan 12 2012 
Weekly Top Insider Buys: PM, AIG, GM, DOW, MED May 30 2011 
Medifast Inc. (MED) President and COO Margaret Macdonald Sheetz sells 15,000 Shares Jan 07 2011 
Medifast Inc. (MED) CFO Brendan Connors sells 20,000 Shares Jan 07 2011 
Medifast Inc. (MED) Exec. Chairman of the Board Bradley T Macdonald sells 50,000 Shares Jan 07 2011 
Medifast Inc. (MED) CEO Michael S Mcdevitt sells 95,000 Shares Jan 07 2011 
Profit from a Overweight America: Medifast, Nutrisystem, Weight Watchers Jul 03 2010 

More From Our Partners
Interesting AMED Put And Call For July May 20 2013 - THESTREET

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial